A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression
The "One world, one health" initiative emphasizes the need for new strategies to control human and animal tuberculosis (TB) based on their shared interface. A good example would be the development of novel universal vaccines against Mycobacterium tuberculosis complex (MTBC) infection. This...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Journal article |
Published: |
2013
|
_version_ | 1826270391500275712 |
---|---|
author | Perez de Val, B Vidal, E Villarreal-Ramos, B Gilbert, S Andaluz, A Moll, X Martin, M Nofrarias, M Mcshane, H Vordermeier, H Domingo, M |
author_facet | Perez de Val, B Vidal, E Villarreal-Ramos, B Gilbert, S Andaluz, A Moll, X Martin, M Nofrarias, M Mcshane, H Vordermeier, H Domingo, M |
author_sort | Perez de Val, B |
collection | OXFORD |
description | The "One world, one health" initiative emphasizes the need for new strategies to control human and animal tuberculosis (TB) based on their shared interface. A good example would be the development of novel universal vaccines against Mycobacterium tuberculosis complex (MTBC) infection. This study uses the goat model, a natural TB host, to assess the protective effectiveness of a new vaccine candidate in combination with Bacillus Calmette-Guerin (BCG) vaccine. Thirtythree goat kids were divided in three groups: Group 1) vaccinated with BCG (week 0), Group 2) vaccinated with BCG and boosted 8 weeks later with a recombinant adenovirus expressing the MTBC antigens Ag85A, TB10.4, TB9.8 and Acr2 (AdTBF), and Group 3) unvaccinated controls. Later on, an endobronchial challenge with a low dose of M. caprae was performed (week 15). After necropsy (week 28), the pulmonary gross pathology was quantified using high resolution Computed Tomography. Small granulomatous pulmonary lesions (< 0.5 cm diameter) were also evaluated through a comprehensive qualitative histopathological analysis. M. caprae CFU were counted from pulmonary lymph nodes. The AdTBF improved the effects of BCG reducing gross lesion volume and bacterial load, as well as increasing weight gain. The number of Ag85A-specific gamma interferon-producing memory T-cells was identified as a predictor of vaccine efficacy. Specific cellular and humoral responses were measured throughout the 13-week post-challenge period, and correlated with the severity of lesions. Unvaccinated goats exhibited the typical pathological features of active TB in humans and domestic ruminants, while vaccinated goats showed only very small lesions. The data presented in this study indicate that multi-antigenic adenoviral vectored vaccines boosts protection conferred by vaccination with BCG. © 2013 Pérez de Val et al. |
first_indexed | 2024-03-06T21:40:05Z |
format | Journal article |
id | oxford-uuid:479d64c3-b9f8-4142-9b59-012c316ca0f7 |
institution | University of Oxford |
last_indexed | 2024-03-06T21:40:05Z |
publishDate | 2013 |
record_format | dspace |
spelling | oxford-uuid:479d64c3-b9f8-4142-9b59-012c316ca0f72022-03-26T15:21:07ZA Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease ProgressionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:479d64c3-b9f8-4142-9b59-012c316ca0f7Symplectic Elements at Oxford2013Perez de Val, BVidal, EVillarreal-Ramos, BGilbert, SAndaluz, AMoll, XMartin, MNofrarias, MMcshane, HVordermeier, HDomingo, MThe "One world, one health" initiative emphasizes the need for new strategies to control human and animal tuberculosis (TB) based on their shared interface. A good example would be the development of novel universal vaccines against Mycobacterium tuberculosis complex (MTBC) infection. This study uses the goat model, a natural TB host, to assess the protective effectiveness of a new vaccine candidate in combination with Bacillus Calmette-Guerin (BCG) vaccine. Thirtythree goat kids were divided in three groups: Group 1) vaccinated with BCG (week 0), Group 2) vaccinated with BCG and boosted 8 weeks later with a recombinant adenovirus expressing the MTBC antigens Ag85A, TB10.4, TB9.8 and Acr2 (AdTBF), and Group 3) unvaccinated controls. Later on, an endobronchial challenge with a low dose of M. caprae was performed (week 15). After necropsy (week 28), the pulmonary gross pathology was quantified using high resolution Computed Tomography. Small granulomatous pulmonary lesions (< 0.5 cm diameter) were also evaluated through a comprehensive qualitative histopathological analysis. M. caprae CFU were counted from pulmonary lymph nodes. The AdTBF improved the effects of BCG reducing gross lesion volume and bacterial load, as well as increasing weight gain. The number of Ag85A-specific gamma interferon-producing memory T-cells was identified as a predictor of vaccine efficacy. Specific cellular and humoral responses were measured throughout the 13-week post-challenge period, and correlated with the severity of lesions. Unvaccinated goats exhibited the typical pathological features of active TB in humans and domestic ruminants, while vaccinated goats showed only very small lesions. The data presented in this study indicate that multi-antigenic adenoviral vectored vaccines boosts protection conferred by vaccination with BCG. © 2013 Pérez de Val et al. |
spellingShingle | Perez de Val, B Vidal, E Villarreal-Ramos, B Gilbert, S Andaluz, A Moll, X Martin, M Nofrarias, M Mcshane, H Vordermeier, H Domingo, M A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression |
title | A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression |
title_full | A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression |
title_fullStr | A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression |
title_full_unstemmed | A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression |
title_short | A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression |
title_sort | multi antigenic adenoviral vectored vaccine improves bcg induced protection of goats against pulmonary tuberculosis infection and prevents disease progression |
work_keys_str_mv | AT perezdevalb amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT vidale amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT villarrealramosb amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT gilberts amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT andaluza amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT mollx amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT martinm amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT nofrariasm amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT mcshaneh amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT vordermeierh amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT domingom amultiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT perezdevalb multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT vidale multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT villarrealramosb multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT gilberts multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT andaluza multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT mollx multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT martinm multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT nofrariasm multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT mcshaneh multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT vordermeierh multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression AT domingom multiantigenicadenoviralvectoredvaccineimprovesbcginducedprotectionofgoatsagainstpulmonarytuberculosisinfectionandpreventsdiseaseprogression |